Company
Insmed Incorporated
NASDAQ:INSM
Insmed is dedicated to improving the lives of patients battling serious and rare diseases. Our mission is to develop novel, transformational therapies that make a real difference to patients.
5 stories
Insmed gets green light for first drug to treat a rare and chronic lung disease
Arikayce is the first and only therapy approved in the US for patients with MAC lung disease, a chronic and debilitating condition